SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xinxin Mao, Jiuming He, Tiegang Li, Zhaohui Lu, Jian Sun, Yunxiao Meng, Zeper Abliz, Jie Chen, Application of imaging mass spectrometry for the molecular diagnosis of human breast tumors, Scientific Reports, 2016, 6, 21043

    CrossRef

  2. 2
    C. K. Y. Ng, A. M. Schultheis, F.-C. Bidard, B. Weigelt, J. S. Reis-Filho, Breast Cancer Genomics from Microarrays to Massively Parallel Sequencing: Paradigms and New Insights, JNCI Journal of the National Cancer Institute, 2015, 107, 5, djv015

    CrossRef

  3. 3
    Jan Budczies, Michael Bockmayr, Carsten Denkert, Frederick Klauschen, Jochen K Lennerz, Balázs Györffy, Manfred Dietel, Sibylle Loibl, Wilko Weichert, Albrecht Stenzinger, Classical pathology and mutational load of breast cancer – integration of two worlds, The Journal of Pathology: Clinical Research, 2015, 1, 4
  4. 4
    Xi-Yu Liu, Yi-Zhou Jiang, Yi-Rong Liu, Wen-Jia Zuo, Zhi-Ming Shao, Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast, Medicine, 2015, 94, 31, e1309

    CrossRef

  5. 5
    Ling Zhang, Ningyang Jia, Lujun Han, Lei Yang, Weimin Xu, Weiguo Chen, Comparative Analysis of Imaging and Pathology Features of Mucinous Carcinoma of the Breast, Clinical Breast Cancer, 2015, 15, 2, e147

    CrossRef

  6. 6
    Reetu Kundu, Harsh Mohan, Usha Dalal, Uma Handa, Amit Kumar, Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast, Journal of Cytology, 2015, 32, 1, 1

    CrossRef

  7. 7
    Yizi Cong, Guangdong Qiao, Haidong Zou, Jun Lin, Xingmiao Wang, Xiaohui Li, Yalun Li, Shiguang Zhu, Invasive cribriform carcinoma of the breast: A report of nine cases and a review of the literature, Oncology Letters, 2015,

    CrossRef

  8. 8
    ShailjaPuri Wahal, MadhuMati Goel, Raj Mehrotra, Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer, Journal of Cancer Research and Therapeutics, 2015, 11, 4, 798

    CrossRef

  9. 9
    Samuel O Ogunbiyi, Sooyoung Lee, John Mathew, Kwok Leung Cheung, Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome, Future Oncology, 2015, 11, 2, 259

    CrossRef

  10. 10
    Gustav J. Ullenhag, Ahmad Al-Attar, Abhik Mukherjee, Andrew R. Green, Ian O. Ellis, Lindy G. Durrant, The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosis, Journal of Cancer Research and Clinical Oncology, 2015, 141, 3, 505

    CrossRef

  11. 11
    Fabrício F. T. Barros, Tarek M. A. Abdel-Fatah, Paul Moseley, Christopher C. Nolan, Alice C. Durham, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Andrew R. Green, Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay, Breast Cancer Research and Treatment, 2014, 144, 2, 273

    CrossRef

  12. 12
    Tarek M. A. Abdel-Fatah, Christina Perry, Paul Moseley, Kerstie Johnson, Arvind Arora, Stephen Chan, Ian O Ellis, Srinivasan Madhusudan, Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer, Breast Cancer Research and Treatment, 2014, 143, 3, 411

    CrossRef

  13. 13
    Larry Zhao, Xiaofang Yang, Ashraf Khan, Dina Kandil, Diagnostic Role of Immunohistochemistry in the Evaluation of Breast Pathology Specimens, Archives of Pathology & Laboratory Medicine, 2014, 138, 1, 16

    CrossRef

  14. 14
    Tarek M.A. Abdel-Fatah, Roslin Russell, Devika Agarwal, Paul Moseley, Michael Ayotunde Abayomi, Christina Perry, Nada Albarakati, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, Srinivasan Madhusudan, DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts, Molecular Oncology, 2014, 8, 3, 520

    CrossRef

  15. 15
    Andrew R. Green, Fabrício F. T. Barros, Tarek M. A. Abdel-Fatah, Paul Moseley, Christopher C. Nolan, Alice C. Durham, Emad A. Rakha, Stephen Chan, Ian O. Ellis, HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer, Breast Cancer Research and Treatment, 2014, 145, 1, 33

    CrossRef

  16. 16
    A. Lebeau, M. Kriegsmann, E. Burandt, H.-P. Sinn, Invasive Mammakarzinome: Die aktuelle WHO-Klassifikation, Der Pathologe, 2014, 35, 1, 7

    CrossRef

  17. 17
    H.-P. Sinn, B. Helmchen, J. Heil, S. Aulmann, Lobuläre Neoplasie und invasives lobuläres Mammakarzinom, Der Pathologe, 2014, 35, 1, 45

    CrossRef

  18. 18
    Antonio Galzerano, Nicola Rocco, Antonello Accurso, Giuseppe Ciancia, Anna Cipolletta Campanile, Ferdinando Caccavello, Franco Fulciniti, Medullary breast carcinoma in an 18-year-old female: Report on one case diagnosed on fine-needle cytology sample, Diagnostic Cytopathology, 2014, 42, 5
  19. 19
    Nadia Harbeck, Karl Sotlar, Rachel Wuerstlein, Sophie Doisneau-Sixou, Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow, Cancer Treatment Reviews, 2014, 40, 3, 434

    CrossRef

  20. 20
    Bharath Rudraraju, Marjolein Droog, Tarek M. A. Abdel-Fatah, Wilbert Zwart, Athina Giannoudis, Mohammed I. Malki, David Moore, Hetal Patel, Jacqui Shaw, Ian O. Ellis, Steve Chan, Greg N. Brooke, Ekaterina Nevedomskaya, Christiana Lo Nigro, Jason Carroll, R. Charles Coombes, Charlotte Bevan, Simak Ali, Carlo Palmieri, Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer, Breast Cancer Research and Treatment, 2014, 147, 2, 295

    CrossRef

  21. 21
    O. Brouckaert, A. Laenen, A. Smeets, M.R. Christiaens, I. Vergote, H. Wildiers, P. Moerman, G. Floris, P. Neven, Prognostic implications of lobular breast cancer histology: New insights from a single hospital cross-sectional study and SEER data, The Breast, 2014, 23, 4, 371

    CrossRef

  22. 22
    Catalina Acevedo, Claudia Amaya, Jose-Luis López-Guerra, Rare breast tumors: Review of the literature, Reports of Practical Oncology & Radiotherapy, 2014, 19, 4, 267

    CrossRef

  23. 23
    David P. Arps, Julie M. Jorns, Lili Zhao, Jessica Bensenhaver, Celina G. Kleer, Judy C. Pang, Re-Excision Rates of Invasive Ductal Carcinoma with Lobular Features Compared with Invasive Ductal Carcinomas and Invasive Lobular Carcinomas of the Breast, Annals of Surgical Oncology, 2014, 21, 13, 4152

    CrossRef

  24. 24
    Kyuichi Kadota, Yi-Chen Yeh, Camelia S Sima, Valerie W Rusch, Andre L Moreira, Prasad S Adusumilli, William D Travis, The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype, Modern Pathology, 2014, 27, 5, 690

    CrossRef

  25. 25
    Ryan Patrick McMullin, Dennis Charles Sgroi, TheHOXB13:IL17BRbiomarker: prognostic for late recurrence and predictive for benefit from endocrine therapy, Breast Cancer Management, 2014, 3, 2, 155

    CrossRef

  26. 26
    Giuseppe Viale, Characterization and clinical impact of residual disease after neoadjuvant chemotherapy, The Breast, 2013, 22, S88

    CrossRef

  27. 27
    Kaushik Saha, Gargi Raychaudhuri, BitanKumar Chattopadhyay, Clinico-pathological study of breast carcinoma: A prospective two-year study in a tertiary care hospital, Clinical Cancer Investigation Journal, 2013, 2, 1, 34

    CrossRef

  28. 28
    Inhye Park, Jiyoung Kim, Minkuk Kim, Soo Youn Bae, Se Kyung Lee, Won Ho Kil, Jeong Eon Lee, Seok Jin Nam, Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma, Journal of Breast Cancer, 2013, 16, 4, 417

    CrossRef

  29. 29
    Emad A Rakha, Tsu K Teoh, Andrew H S Lee, Chris C Nolan, Ian O Ellis, Andrew R Green, Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study, Histopathology, 2013, 62, 5
  30. 30
    Silvia Dellapasqua, Patrick Maisonneuve, Giuseppe Viale, Giancarlo Pruneri, Giovanni Mazzarol, Raffaella Ghisini, Manuelita Mazza, Monica Iorfida, Nicole Rotmensz, Paolo Veronesi, Alberto Luini, Aron Goldhirsch, Marco Colleoni, Immunohistochemically Defined Subtypes and Outcome of Apocrine Breast Cancer, Clinical Breast Cancer, 2013, 13, 2, 95

    CrossRef

  31. 31
    Umberto Veronesi, Roberto Orecchia, Patrick Maisonneuve, Giuseppe Viale, Nicole Rotmensz, Claudia Sangalli, Alberto Luini, Paolo Veronesi, Viviana Galimberti, Stefano Zurrida, Maria Cristina Leonardi, Roberta Lazzari, Federica Cattani, Oreste Gentilini, Mattia Intra, Pietro Caldarella, Bettina Ballardini, Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial, The Lancet Oncology, 2013, 14, 13, 1269

    CrossRef

  32. 32
    David P. Arps, Patrick Healy, Lili Zhao, Celina G. Kleer, Judy C. Pang, Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast, Breast Cancer Research and Treatment, 2013, 138, 3, 719

    CrossRef

  33. 33
    Hasan Gokce, Merih Guray Durak, Mehmet Mustafa Akin, Tulay Canda, Pinar Balci, Hulya Ellidokuz, Binnaz Demirkan, Ilknur Bilkay Gorken, Ali Ibrahim Sevinc, Mehmet Ali Kocdor, Serdar Saydam, Omer Harmancioglu, Invasive Micropapillary Carcinoma of the Breast: A Clinicopathologic Study of 103 Cases of an Unusual and Highly Aggressive Variant of Breast Carcinoma, The Breast Journal, 2013, 19, 4
  34. 34
    L S Rigter, C E Loo, S C Linn, G S Sonke, E van Werkhoven, E H Lips, H A Warnars, P K Doll, A Bruining, I A Mandjes, M J Vrancken Peeters, J Wesseling, K G Gilhuijs, S Rodenhuis, Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer, British Journal of Cancer, 2013, 109, 12, 2965

    CrossRef

  35. 35
    Adriana D. Corben, Pathology of Invasive Breast Disease, Surgical Clinics of North America, 2013, 93, 2, 363

    CrossRef

  36. 36
    J. Cyrta, F. Andreiuolo, S. Azoulay, C. Balleyguier, C. Bourgier, C. Mazouni, M.-C. Mathieu, S. Delaloge, P. Vielh, Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literature, Cytopathology, 2013, 24, 6
  37. 37
    R.W. Blamey, T. Bates, U. Chetty, S.W. Duffy, I.O. Ellis, D. George, E. Mallon, M.J. Mitchell, I. Monypenny, D.A.L. Morgan, R.D. Macmillan, J. Patnick, S.E. Pinder, Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial, European Journal of Cancer, 2013, 49, 10, 2294

    CrossRef

  38. 38
    S. J. Nyante, C. M. Dallal, G. L. Gierach, Y. Park, A. R. Hollenbeck, L. A. Brinton, Risk Factors for Specific Histopathological Types of Postmenopausal Breast Cancer in the NIH-AARP Diet and Health Study, American Journal of Epidemiology, 2013, 178, 3, 359

    CrossRef

  39. 39
    Tarek M. A. Abdel-Fatah, Nada Albarakati, Lara Bowell, Devika Agarwal, Paul Moseley, Claire Hawkes, Graham Ball, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan, Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy, Breast Cancer Research and Treatment, 2013, 142, 3, 515

    CrossRef

  40. 40
    Louisa M Gannon, Maura B Cotter, Cecily M Quinn, The classification of invasive carcinoma of the breast, Expert Review of Anticancer Therapy, 2013, 13, 8, 941

    CrossRef

  41. 41
    Abeer M. Shaaban, Graham R. Ball, Rebecca A. Brannan, Gabor Cserni, Anna Di Benedetto, Jo Dent, Laura Fulford, Helen Honarpisheh, Lee Jordan, J. Louise Jones, Rani Kanthan, Loaie Maraqa, Maria Litwiniuk, Marcella Mottolese, Steven Pollock, Elena Provenzano, Philip R. Quinlan, Georgina Reall, Sami Shousha, Mark Stephens, Eldo T. Verghese, Rosemary A. Walker, Andrew M. Hanby, Valerie Speirs, A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences, Breast Cancer Research and Treatment, 2012, 133, 3, 949

    CrossRef

  42. 42
    Aaron Boudreau, Laura J. van't Veer, Mina J. Bissell, An “elite hacker”, Cell Adhesion & Migration, 2012, 6, 3, 236

    CrossRef

  43. 43
    Ayodeji J. Agboola, E. Claire Paish, Emad A. Rakha, Desmond G. Powe, R. Douglas Macmillan, Ian O. Ellis, Andrew R. Green, EpCAM expression is an indicator of recurrence in basal-like breast cancer, Breast Cancer Research and Treatment, 2012, 133, 2, 575

    CrossRef

  44. 44
    Bryce P. Portier, Aaron M. Gruver, Michael A. Huba, Eugen C. Minca, Alison L. Cheah, Zhen Wang, Raymond R. Tubbs, From morphologic to molecular: established and emerging molecular diagnostics for breast carcinoma, New Biotechnology, 2012, 29, 6, 665

    CrossRef

  45. 45
    Marianna Philippidou, Sarah E. Pinder, Invasive Lobular Carcinoma of the Breast, Surgical Pathology Clinics, 2012, 5, 3, 545

    CrossRef

  46. 46
    Justin Stebbing, Aleksandra Filipovic, Ian O. Ellis, Andrew R. Green, Tanya Rapoz D’Silva, Heinz-Josef Lenz, R. Charles Coombes, Tingting Wang, Soo-Chin Lee, Georgios Giamas, LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome, Breast Cancer Research and Treatment, 2012, 132, 2, 537

    CrossRef

  47. 47
    Amani Hussein Kazem, Malak Ahmed Zoheir, Khaled El Sayed Soliman, Naglaa Mohamed Elshazly, Maspin expression in breast carcinoma, Egyptian Journal of Pathology, 2012, 32, 1, 165

    CrossRef

  48. 48
    M. Colleoni, N. Rotmensz, P. Maisonneuve, M. G. Mastropasqua, A. Luini, P. Veronesi, M. Intra, E. Montagna, G. Cancello, A. Cardillo, M. Mazza, G. Perri, M. Iorfida, G. Pruneri, A. Goldhirsch, G. Viale, Outcome of special types of luminal breast cancer, Annals of Oncology, 2012, 23, 6, 1428

    CrossRef

  49. 49
    S. M. A. Mahmoud, A. H. S. Lee, E. C. Paish, R. D. Macmillan, I. O. Ellis, A. R. Green, The prognostic significance of B lymphocytes in invasive carcinoma of the breast, Breast Cancer Research and Treatment, 2012, 132, 2, 545

    CrossRef

  50. 50
    Emad A. Rakha, Stewart Martin, Andrew H. S. Lee, David Morgan, Paul D. P. Pharoah, Zsolt Hodi, Douglas MacMillan, Ian O. Ellis, The prognostic significance of lymphovascular invasion in invasive breast carcinoma, Cancer, 2012, 118, 15
  51. 51
    Felipe C. Geyer, Jorge S. Reis-Filho, David J. Dabbs, Breast Pathology, 2012,

    CrossRef

  52. 52
    Emad A. Rakha, Ian O. Ellis, Breast Pathology, 2012,

    CrossRef

  53. 53
    Sunati Sahoo, Sandra J. Shin, Breast Pathology, 2012,

    CrossRef

  54. 54
    Marco Colleoni, Leila Russo, Silvia Dellapasqua, Adjuvant therapies for special types of breast cancer, The Breast, 2011, 20, S153

    CrossRef

  55. 55
    Sahar M. A. Mahmoud, Emma C. Paish, Desmond G. Powe, R. Douglas Macmillan, Andrew H. S. Lee, Ian O. Ellis, Andrew R. Green, An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer, Breast Cancer Research and Treatment, 2011, 127, 1, 99

    CrossRef

  56. 56
    Paraskevi Chatzidaki, Chrysovalantis Mellos, Volker Briese, Ioannis Mylonas, Does primary breast cancer in older women (≥80 years) have unfavorable histological characteristics?, Archives of Gynecology and Obstetrics, 2011, 284, 3, 705

    CrossRef

  57. 57
    Viviana Galimberti, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Viale, Claudia Sangalli, Manuela Sargenti, Fabricio Brenelli, Oreste Gentilini, Mattia Intra, Fabio Bassi, Alberto Luini, Stefano Zurrida, Paolo Veronesi, Marco Colleoni, Umberto Veronesi, Influence of Margin Status on Outcomes in Lobular Carcinoma, Annals of Surgery, 2011, 253, 3, 580

    CrossRef

  58. 58
    M. J. Hoenerhoff, M. A. Shibata, A. Bode, J. E. Green, Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer, Transgenic Research, 2011, 20, 2, 247

    CrossRef

  59. 59
    Hany Onsy Habashy, Desmond G. Powe, Enrico Glaab, Graham Ball, Inmaculada Spiteri, Natalio Krasnogor, Jonathan M. Garibaldi, Emad A. Rakha, Andrew R. Green, C. Caldas, Ian O. Ellis, RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype, Breast Cancer Research and Treatment, 2011, 128, 2, 315

    CrossRef

  60. 60
    Michael D. Stamatakos, Early Diagnosis and Treatment of Cancer Series: Breast Cancer, 2011,

    CrossRef

  61. 61
    Peter T. Simpson, Jorge S. Reis-Filho, Sunil R. Lakhani, Breast pathology: beyond morphology, Seminars in Diagnostic Pathology, 2010, 27, 1, 91

    CrossRef

  62. 62
    Pamela Klingbeil, Rachael Natrajan, Gemma Everitt, Radost Vatcheva, Caterina Marchio, Jose Palacios, Horst Buerger, Jorge S. Reis-Filho, Clare M. Isacke, CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification, Breast Cancer Research and Treatment, 2010, 120, 1, 95

    CrossRef

  63. 63
    Emad A. Rakha, Arjun Patel, Des G. Powe, Ahmed Benhasouna, Andrew R. Green, Maryou B. Lambros, Jorge S. Reis-Filho, Ian O. Ellis, Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the Breast, The American Journal of Surgical Pathology, 2010, 34, 10, 1472

    CrossRef

  64. 64
    Zsolt Hodi, Ian O Ellis, Christopher W Elston, Sarah E Pinder, Glynn Donovan, R Douglas Macmillan, Andrew H S Lee, Comparison of margin assessment by radial and shave sections in wide local excision specimens for invasive carcinoma of the breast, Histopathology, 2010, 56, 5
  65. 65
    Jorma J. de Ronde, Juliane Hannemann, Hans Halfwerk, Lennart Mulder, Marieke E. Straver, Marie-Jeanne T. F. D. Vrancken Peeters, Jelle Wesseling, Marc van de Vijver, Lodewyk F. A. Wessels, Sjoerd Rodenhuis, Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response, Breast Cancer Research and Treatment, 2010, 119, 1, 119

    CrossRef

  66. 66
    Britta Weigelt, Felipe C. Geyer, Jorge S. Reis-Filho, Histological types of breast cancer: How special are they?, Molecular Oncology, 2010, 4, 3, 192

    CrossRef

  67. 67
    Ita Hadžisejdić, Elvira Mustać, Nives Jonjić, Marija Petković, Blaženka Grahovac, Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis, Modern Pathology, 2010, 23, 3, 392

    CrossRef

  68. 68
    H. Zhang, E. A. Rakha, G. R. Ball, I. Spiteri, M. Aleskandarany, E. C. Paish, D. G. Powe, R. D. Macmillan, C. Caldas, I. O. Ellis, A. R. Green, The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer, Breast Cancer Research and Treatment, 2010, 121, 1, 41

    CrossRef

  69. 69
    Jae-Won Oh, Seho Park, Joo-Hee Kim, Ja-Seung Koo, Ho Hur, Woo-Ick Yang, Byeong-Woo Park, Kyong-Sik Lee, Clinical Analysis of Medullary Carcinoma of the Breast, Journal of Breast Cancer, 2009, 12, 1, 47

    CrossRef

  70. 70
    Britta Weigelt, Jorge S. Reis-Filho, Histological and molecular types of breast cancer: is there a unifying taxonomy?, Nature Reviews Clinical Oncology, 2009, 6, 12, 718

    CrossRef

  71. 71
    Giuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, Enrico Orvieto, Eugenio Maiorano, Viviana Galimberti, Alberto Luini, Marco Colleoni, Aron Goldhirsch, Alan S. Coates, Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series, Breast Cancer Research and Treatment, 2009, 117, 1, 211

    CrossRef

  72. 72
    Rachael Natrajan, Maryou B. K. Lambros, Felipe C. Geyer, Caterina Marchio, David S. P. Tan, Radost Vatcheva, Kai-Keen Shiu, Daniela Hungermann, Socorro Maria Rodriguez-Pinilla, Jose Palacios, Alan Ashworth, Horst Buerger, Jorge S. Reis-Filho, Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?, Genes, Chromosomes and Cancer, 2009, 48, 4
  73. 73
    Menaka D. S. Lokuhetty, Gayani G. Ranaweera, Manarangi D. M. Wijeratne, Kumudu H. Wickramasinghe, Abdul H. Sheriffdeen, Profile of Breast Cancer in a Group of Women in a Developing Country in South Asia: Is There a Difference?, World Journal of Surgery, 2009, 33, 3, 455

    CrossRef

  74. 74
    I. T. H. Au-Yong, A. J. Evans, S. Taneja, E. A. Rakha, A. R. Green, C. Paish, I. O. Ellis, Sonographic correlations with the new molecular classification of invasive breast cancer, European Radiology, 2009, 19, 10, 2342

    CrossRef

  75. 75
    Emad A. Rakha, Muhammad S. Gill, Maysa E. El-Sayed, Marium M. Khan, Zsolt Hodi, Roger W. Blamey, Andrew J. Evans, Andrew H. S. Lee, Ian O. Ellis, The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology, Breast Cancer Research and Treatment, 2009, 114, 2, 243

    CrossRef

  76. 76
    E.A. Rakha, M. Aleskandarany, M.E. El-Sayed, R.W. Blamey, C.W. Elston, I.O. Ellis, A.H.S. Lee, The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast, European Journal of Cancer, 2009, 45, 10, 1780

    CrossRef

  77. 77
    NOEL WEIDNER, Farnaz Hasteh, Modern Surgical Pathology, 2009,

    CrossRef

  78. 78
    L.S. Kilburn, ‘Triple Negative’ Breast Cancer: a New Area for Phase III Breast Cancer Clinical Trials, Clinical Oncology, 2008, 20, 1, 35

    CrossRef

  79. 79
    JS Reis-Filho, SR Lakhani, Breast cancer special types: why bother?, The Journal of Pathology, 2008, 216, 4
  80. 80
    Sebastian Aulmann, Roland Penzel, Thomas Longerich, Benjamin Funke, Peter Schirmacher, Hans Peter Sinn, Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer, Breast Cancer Research and Treatment, 2008, 107, 3, 331

    CrossRef

  81. 81
    Emad A. Rakha, Somaia E. El-Sheikh, Mona A. Kandil, Maysa E. El-Sayed, Andrew R. Green, Ian O. Ellis, Expression of BRCA1 protein in breast cancer and its prognostic significance, Human Pathology, 2008, 39, 6, 857

    CrossRef

  82. 82
    Emad A. Rakha, Maysa E. El-Sayed, Sindhu Menon, Andrew R. Green, Andrew H. S. Lee, Ian O. Ellis, Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast, Breast Cancer Research and Treatment, 2008, 111, 1, 121

    CrossRef

  83. You have free access to this content83
    A M Hanby, T A Hughes, In situ and invasive lobular neoplasia of the breast, Histopathology, 2008, 52, 1
  84. 84
    Emad A. Rakha, Maysa E. El-Sayed, Desmond G. Powe, Andrew R. Green, Hany Habashy, Matthew J. Grainge, John F.R. Robertson, Roger Blamey, Julia Gee, Robert I. Nicholson, Andrew H.S. Lee, Ian O. Ellis, Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes, European Journal of Cancer, 2008, 44, 1, 73

    CrossRef

  85. 85
    W. Böcker, T. Decker, Pathologie des invasiven Mammakarzinoms, Der Onkologe, 2008, 14, 5, 443

    CrossRef

  86. 86
    S. Taneja, A.J. Evans, E.A. Rakha, A.R. Green, G. Ball, I.O. Ellis, The mammographic correlations of a new immunohistochemical classification of invasive breast cancer, Clinical Radiology, 2008, 63, 11, 1228

    CrossRef

  87. 87
    Andrew R. Green, Claire Burney, Christopher J. Granger, E. Claire Paish, Somaia El-Sheikh, Emad A. Rakha, Desmond G. Powe, R. Douglas Macmillan, Ian O. Ellis, Eleni Stylianou, The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome, Breast Cancer Research and Treatment, 2008, 110, 3, 427

    CrossRef

  88. 88
    A McCarthy, K Savage, A Gabriel, C Naceur, JS Reis-Filho, A Ashworth, A mouse model of basal-like breast carcinoma with metaplastic elements, The Journal of Pathology, 2007, 211, 4
  89. 89
    Francisco Javier Torres Gómez, Francisco Javier Torres Olivera, Correlación entre parámetros morfológicos y expresión inmunohistoquímica de factores pronósticos en el carcinoma ductal infiltrante de mama, Revista Española de Patología, 2007, 40, 4, 217

    CrossRef

  90. 90
    Ossama Tawfik, Bruce F. Kimler, Marilyn Davis, Christopher Stasik, Sue-Min Lai, Matthew S. Mayo, Fang Fan, John K. Donahue, Ivan Damjanov, Patricia Thomas, Carol Connor, William R. Jewell, Holly Smith, Carol J. Fabian, Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count, Virchows Archiv, 2007, 450, 6, 627

    CrossRef

  91. 91
    Rabab A. A. Mohammed, Stewart G. Martin, Muhammad S. Gill, Andrew R. Green, Emma C. Paish, Ian O. Ellis, Improved Methods of Detection of Lymphovascular Invasion Demonstrate That It is the Predominant Method of Vascular Invasion in Breast Cancer and has Important Clinical Consequences, The American Journal of Surgical Pathology, 2007, 31, 12, 1825

    CrossRef

  92. 92
    Maj-Lis Møller Talman, Maj-Britt Jensen, Fritz Rank, Invasive lobular breast cancer. Prognostic significance of histological malignancy grading, Acta Oncologica, 2007, 46, 6, 803

    CrossRef

  93. 93
    G.J.R. Porter, A.J. Evans, H.C. Burrell, A.H.S. Lee, J. Chakrabarti, NHSBSP type 1 interval cancers: a scientifically valid grouping?, Clinical Radiology, 2007, 62, 3, 262

    CrossRef

  94. 94
    Anna Marie Mulligan, Frances P. O??Malley, Papillary Lesions of the Breast, Advances in Anatomic Pathology, 2007, 14, 2, 108

    CrossRef

  95. 95
    Gábor Cserni, Simonetta Bianchi, Vania Vezzosi, Riccardo Arisio, Rita Bori, Johannes L. Peterse, Anna Sapino, Maria Drijkoningen, Janina Kulka, Vincenzo Eusebi, Maria Pia Foschini, Jean-Pierre Bellocq, Cristi Marin, Sten Thorstenson, Isabel Amendoeira, Angelika Reiner-Concin, Thomas Decker, Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis, European Journal of Cancer, 2007, 43, 9, 1407

    CrossRef

  96. 96
    Edurne Arriola, Socorro Maria Rodriguez-Pinilla, Maryou B. K. Lambros, Robin L. Jones, Michelle James, Kay Savage, Ian E. Smith, Mitch Dowsett, Jorge S. Reis-Filho, Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer, Breast Cancer Research and Treatment, 2007, 106, 2, 181

    CrossRef

  97. 97
    Marieke W.J. Louwman, Martine Vriezen, Mike W.P.M. van Beek, M. Cathelijne B.J.E. Tutein Nolthenius-Puylaert, Maurice J.C. van der Sangen, Rudi M. Roumen, Lambertus A.L.M. Kiemeney, Jan Willem W. Coebergh, Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands, International Journal of Cancer, 2007, 121, 1
  98. 98
    C Marchiò, A Sapino, R Arisio, G Bussolati, A new vision of tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D modelling, Histopathology, 2006, 48, 5
  99. 99
    Emad A. Rakha, Dalia Abd El-Rehim, Claire Paish, Andrew R. Green, Andrew H.S. Lee, John F. Robertson, Roger W. Blamey, Douglas Macmillan, Ian O. Ellis, Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance, European Journal of Cancer, 2006, 42, 18, 3149

    CrossRef

  100. 100
    Jorge S Reis-Filho, Kay Savage, Maryou B K Lambros, Michelle James, Dawn Steele, Robin L Jones, Mitch Dowsett, Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis, Modern Pathology, 2006, 19, 7, 999

    CrossRef

  101. 101
    Bernadette K. McLaren, Peggy A. Schuyler, Melinda E. Sanders, Roy A. Jensen, Jean F. Simpson, William D. Dupont, David L. Page, Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy, Cancer, 2006, 107, 6
  102. 102
    EA Rakha, TC Putti, DM Abd El-Rehim, C Paish, AR Green, DG Powe, AH Lee, JF Robertson, IO Ellis, Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation, The Journal of Pathology, 2006, 208, 4
  103. 103
    A.H.S. Lee, S.E. Pinder, R.D. Macmillan, M. Mitchell, I.O. Ellis, C.W. Elston, R.W. Blamey, Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma, European Journal of Cancer, 2006, 42, 3, 357

    CrossRef

  104. 104
    J. Leikola, P. Heikkilä, K. von Smitten, M. Leidenius, The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy, European Journal of Surgical Oncology (EJSO), 2006, 32, 5, 488

    CrossRef

  105. 105
    A M Hanby, Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy, British Journal of Cancer, 2005, 92, 4, 613

    CrossRef

  106. 106
    Ha Vu-Nishino, Fattaneh A. Tavassoli, Willam A. Ahrens, Bruce G. Haffty, Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT), International Journal of Radiation Oncology*Biology*Physics, 2005, 62, 4, 1040

    CrossRef

  107. 107
    E A Rakha, D Abd El Rehim, S E Pinder, S A Lewis, I O Ellis, E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance, Histopathology, 2005, 46, 6
  108. 108
    Thomas C Putti, Dalia M Abd El-Rehim, Emad A Rakha, Claire E Paish, Andrew HS Lee, Sarah E Pinder, Ian O Ellis, Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis, Modern Pathology, 2005, 18, 1, 26

    CrossRef

  109. 109
    Emad A Rakha, Richard W G Boyce, Dalia Abd El-Rehim, Thomas Kurien, Andrew R Green, Emma C Paish, John F R Robertson, Ian O Ellis, Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer, Modern Pathology, 2005, 18, 10, 1295

    CrossRef

  110. 110
    Emad A. Rakha, John A.L. Armour, Sarah E. Pinder, Claire E. Paish, Ian O. Ellis, High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry, International Journal of Cancer, 2005, 114, 5
  111. 111
    Dalia M. Abd El-Rehim, Graham Ball, Sarah E. Pinder, Emad Rakha, Claire Paish, John F.R. Robertson, Douglas Macmillan, Roger W. Blamey, Ian O. Ellis, High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses, International Journal of Cancer, 2005, 116, 3
  112. 112
    Tetsuo Kondo, Tadao Nakazawa, Shin-ichi Murata, Ryohei Katoh, Stromal elastosis in papillary thyroid carcinomas, Human Pathology, 2005, 36, 5, 474

    CrossRef

  113. 113
    A.M. Hanby, The pathology of breast cancer and the role of the histopathology laboratory, Clinical Oncology, 2005, 17, 4, 234

    CrossRef

  114. 114
    Zahra Madjd, Ian Spendlove, Sarah E. Pinder, Ian O. Ellis, Lindy G. Durrant, Total loss of MHC class I is an independent indicator of good prognosis in breast cancer, International Journal of Cancer, 2005, 117, 2
  115. 115
    Tamio Yamasaki, Hitoshi Tsuda, Nobuo Imazeki, Osamu Matsubara, Vascular endothelial growth factor mRNA levels quantified by reverse transcription–polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components, Pathology International, 2005, 55, 5
  116. 116
    P.T.C. Iau, M. Marafie, A. Ali, J.H. Sng, R.D. Macmillan, S. Pinder, H.E. Denley, I.O. Ellis, P. Wenzyck, N. Scott, G. Cross, R.W. Blamey, Are Medullary Breast Cancers an Indication for BRCA1 Mutation Screening? A Mutation Analysis of 42 Cases of Medullary Breast Cancer, Breast Cancer Research and Treatment, 2004, 85, 1, 81

    CrossRef

  117. 117
    D M Abd El-Rehim, S E Pinder, C E Paish, J A Bell, R S Rampaul, R W Blamey, J F R Robertson, R I Nicholson, I O Ellis, Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma, British Journal of Cancer, 2004, 91, 8, 1532

    CrossRef

  118. 118
    E A Rakha, S E Pinder, C E Paish, I O Ellis, Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1, British Journal of Cancer, 2004, 91, 8, 1591

    CrossRef

  119. 119
    Kanji Tanaka, Daigo Yamamoto, Masanori Yamada, Homa Okugawa, Influence of cellularity in human breast carcinoma, The Breast, 2004, 13, 4, 334

    CrossRef

  120. 120
    John H Eichhorn, Medullary carcinoma, provocative now as then, Seminars in Diagnostic Pathology, 2004, 21, 1, 65

    CrossRef

  121. 121
    L.J. Hamilton, A.J. Evans, S.E. Pinder, J.J. James, E. Gutteridge, E.J. Cornford, H.C. Burrell, S.Y. Chan, J.F. Robertson, K.L. Cheung, Metastatic Carcinoma of the Breast with Tubular Features: Differences Compared with Metastatic Ductal Carcinoma of No Specific Type, Clinical Oncology, 2004, 16, 2, 119

    CrossRef

  122. 122
    Sarah A Thurman, Stuart J Schnitt, James L Connolly, Rebecca Gelman, Barbara Silver, Jay R Harris, Abram Recht, Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma, International Journal of Radiation Oncology*Biology*Physics, 2004, 59, 1, 152

    CrossRef

  123. 123
    G.J.R. Porter, A.J. Evans, S.E. Pinder, J.J. James, E.C. Cornford, H.C. Burrell, S.Y. Chan, K.L. Cheung, J.F.R. Robertson, Patterns of metastatic breast carcinoma: influence of tumour histological grade, Clinical Radiology, 2004, 59, 12, 1094

    CrossRef

  124. 124
    J. Kollias, S.E. Pinder, H.E. Denley, I.O. Ellis, P. Wencyk, J.A. Bell, C.W. Elston, R.W. Blamey, Phenotypic similarities in bilateral breast cancer, Breast Cancer Research and Treatment, 2004, 85, 3, 255

    CrossRef

  125. 125
    S Ferlicot, A Vincent-Salomon, J Médioni, P Genin, C Rosty, B Sigal-Zafrani, P Fréneaux, M Jouve, J.-P Thiery, X Sastre-Garau, Wide metastatic spreading in infiltrating lobular carcinoma of the breast, European Journal of Cancer, 2004, 40, 3, 336

    CrossRef

  126. 126
    Gavin C. Harris, Helen E. Denley, Sarah E. Pinder, Andrew H. S. Lee, Ian O. Ellis, Christopher W. Elston, Andrew Evans, Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma, The American Journal of Surgical Pathology, 2003, 27, 1, 11

    CrossRef

  127. 127
    J.J James, A.J Evans, S.E Pinder, R.D Macmillan, A.R.M Wilson, I.O Ellis, Is the Presence of Mammographic Comedo Calcification Really a Prognostic Factor for Small Screen-detected Invasive Breast Cancers?, Clinical Radiology, 2003, 58, 1, 54

    CrossRef

  128. 128
    L.M Kelly, A.D.K Hill, S Kennedy, E.M Connolly, R Ramanath, S Teh, B Dijkstra, R Purcell, E.W McDermott, N O'Higgins, Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up, European Journal of Surgical Oncology (EJSO), 2003, 29, 9, 707

    CrossRef

  129. 129
    David C. Chhieng, Sana O. Tabbara, Edith F. Marley, Lynya I. Talley, Andra R. Frost, Microvessel Density and Vascular Endothelial Growth Factor Expression in Infiltrating Lobular Mammary Carcinoma, The Breast Journal, 2003, 9, 3
  130. 130
    H Lambie, A Miremadi, SE Pinder, JA Bell, P Wencyk, EC Paish, RD Macmillan, IO Ellis, Prognostic significance of BRCA1 expression in sporadic breast carcinomas, The Journal of Pathology, 2003, 200, 2
  131. 131
    George P Skliris, Kailas Munot, Sandra M Bell, Pauline J Carder, Sally Lane, Kieran Horgan, Mark RJ Lansdown, Alicia T Parkes, Andrew M Hanby, Alexander F Markham, Valerie Speirs, Reduced expression of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model, The Journal of Pathology, 2003, 201, 2
  132. 132
    Thomas J. Anderson, Farzana Sufi, Ian O. Ellis, John P. Sloane†, Susan Moss, Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years, Human Pathology, 2002, 33, 3, 365

    CrossRef

  133. 133
    M. Sundquist, S. Thorstenson, L. Brudin, S. Wingren, B. Nordenskjöld, Incidence and prognosis in early onset breast cancer, The Breast, 2002, 11, 1, 30

    CrossRef

  134. 134
    R.S. Rampaul, S.E. Pinder, J.F.R. Robertson, I.O. Ellis, LEA 135 expression in primary invasive breast cancer, The Breast, 2002, 11, 6, 529

    CrossRef

  135. 135
    A Miremadi, S E Pinder, A H S Lee, J A Bell, E C Paish, P Wencyk, C W Elston, R I Nicholson, R W Blamey, J F Robertson, I O Ellis, Neuroendocrine differentiation and prognosis in breast adenocarcinoma, Histopathology, 2002, 40, 3
  136. 136
    R. A. Deb, P. Matthews, C. W. Elston, I. O. Ellis, S. E. Pinder, An audit of ‘equivocal’ (C3) and ‘suspicious’ (C4) categories in fine needle aspiration cytology of the breast, Cytopathology, 2001, 12, 4
  137. 137
    Horst Buerger, Ellen C. Mommers, Ruth Littmann, Ronald Simon, Raihanatou Diallo, Christopher Poremba, Barbara Dockhorn-Dworniczak, Paul J. van Diest, Werner Boecker, Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution, The Journal of Pathology, 2001, 194, 2
  138. 138
    L. Temmim, Y.A. Luqmani, M. Jarallah, I. Juma, M. Mathew, Evaluation of prognostic factors in male breast cancer, The Breast, 2001, 10, 2, 166

    CrossRef

  139. 139
    Aye Aye Thike, Mei Jiuan Chng, Puay Hoon Tan, Stephanie Fook-Chong, Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters, Pathology, 2001, 33, 1, 21

    CrossRef

  140. 140
    James Kollias, Ian O. Ellis, Christopher W. Elston, Roger W. Blamey, Prognostic significance of synchronous and metachronous bilateral breast cancer, World Journal of Surgery, 2001, 25, 9, 1117

    CrossRef

  141. 141
    C.M. Quinn, The pathology of breast screening, Current Diagnostic Pathology, 2001, 7, 2, 81

    CrossRef

  142. 142
    S. J. Schnitt, Traditional and Newer Pathologic Factors, JNCI Monographs, 2001, 2001, 30, 22

    CrossRef

  143. 143
    James J. Going, Elizabeth A. Mallon, Robin E. Leake, John M. Bartlett, Barry A. Gusterson, What the clinician needs from the pathologist: Evidence-based reporting in breast cancer, European Journal of Cancer, 2001, 37, 5

    CrossRef

  144. 144
    J. Kollias, P. G. Gill, B. J. Coventry, P. Malycha, B. Chatterton, G. Farshid, CLINICAL AND HISTOLOGICAL FACTORS ASSOCIATED WITH SENTINEL NODE IDENTIFICATION IN BREAST CANCER, Australian and New Zealand Journal of Surgery, 2000, 70, 7
  145. 145
    F. Joel W.-M. Leong, Andrew K. Graham, Peter Schwarzmann, James O'D. McGee, Clinical Trial of Telepathology As an Alternative Modality in Breast Histopathology Quality Assurance, Telemedicine Journal and e-Health, 2000, 6, 4, 373

    CrossRef

  146. 146
    F Otterbach, À Bànkfalvi, S Bergner, T Decker, R Krech, W Boecker, Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast, Histopathology, 2000, 37, 3
  147. 147
    P.S. Sinha, S. Bendall, T. Bates, Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?, European Journal of Surgical Oncology (EJSO), 2000, 26, 8, 733

    CrossRef

  148. 148
    Steven A. Chappell, Suzanne M. Johnson, Jacqueline A. Shaw, Rosemary A. Walker, Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas, The Journal of Pathology, 2000, 192, 2
  149. 149
    J. Kollias, S. Man, M. Marafie, K. Carpenter, S. Pinder, I.O. Ellis, R.W. Blamey, G. Cross, J.D. Brook, Loss of Heterozygosity in Bilateral Breast Cancer, Breast Cancer Research and Treatment, 2000, 64, 3, 241

    CrossRef

  150. 150
    S Shousha, Medullary carcinoma of the breast and BRCA1 mutation, Histopathology, 2000, 37, 2
  151. 151
    Helge Stalsberg, William H Hartmann, The delimitation of tubular carcinomaof the breast, Human Pathology, 2000, 31, 5, 601

    CrossRef

  152. 152
    M. A. Gonzalez, S. E. Pinder, P. M. Wencyk, J. A. Bell, C. W. Elston, R. I. Nicholson, J. F. R. Robertson, R. W. Blamey, I. O. Ellis, An immunohistochemical examination of the expression of E-cadherin, α- and β/γ-catenins, and α2- and β1-integrins in invasive breast cancer, The Journal of Pathology, 1999, 187, 5
  153. 153
    Marie Sundquist, Sten Thorstenson, Lars Brudin, Bo Nordenskjöld, Applying the Nottingham Prognostic Index to a Swedish breast cancer population, Breast Cancer Research and Treatment, 1999, 53, 1, 1

    CrossRef

  154. 154
    J Kollias, IO Ellis, CW Elston, RW Blamey, Clinical and histological predictors of contralateral breast cancer, European Journal of Surgical Oncology (EJSO), 1999, 25, 6, 584

    CrossRef

  155. 155
    Richard A. McClelland, Julia M. W. Gee, Louise O'Sullivan, Diana M. Barnes, John F. R. Robertson, Ian O. Ellis, Robert I. Nicholson, p21WAF1 expression and endocrine response in breast cancer, The Journal of Pathology, 1999, 188, 2
  156. 156
    Sahar Al-Haddad, Zi Zhang, Etienne Leygue, Linda Snell, Aihua Huang, Yulian Niu, Tamara Hiller-Hitchcock, Kate Hole, Leigh C. Murphy, Peter H. Watson, Psoriasin (S100A7) Expression and Invasive Breast Cancer, The American Journal of Pathology, 1999, 155, 6, 2057

    CrossRef

  157. 157
    Gábor Cserni, Reproducibility of a diagnosis of invasive lobular carcinoma, Journal of Surgical Oncology, 1999, 70, 4
  158. 158
    P.H. Tan, G.S.C. Chiang, E.H. Ng, S.C. Low, F.C. Ng, Screen detected breast cancer in an Asian population: pathological findings of the Singapore breast screening project, The Breast, 1999, 8, 3, 120

    CrossRef

  159. 159
    Adewale Adeyinka, Fredrik Mertens, Ingrid Idvall, Lennart Bondeson, Christian Ingvar, Sverre Heim, Felix Mitelman, Nikos Pandis, Cytogenetic findings in invasive breast carcinomas with prognostically favourable histology: A less complex karyotypic pattern?, International Journal of Cancer, 1998, 79, 4
  160. 160
    Emmanouil Pikoulis, Panayiotis N. Varelas, Juan Lechago, Constantinos Papaconstantinou, Panayiotis J. Asimacopoulos, Metastatic Breast Disease 40 Years After the Initial Diagnosis, Chest, 1998, 114, 2, 639

    CrossRef

  161. 161
    Yunn-Yi Chen, Stuart J. Schnitt, Prognostic factors for patients with breast cancers 1cm and smaller, Breast Cancer Research and Treatment, 1998, 51, 3, 209

    CrossRef

  162. 162
    C.W. Elston, I.O. Ellis, S.E. Pinder, Prognostic factors in invasive carcinoma of the breast, Clinical Oncology, 1998, 10, 1, 14

    CrossRef

  163. 163
    David L. Page, Roy A. Jensen, Jean F. Simpson, Routinely available indicators of prognosis in breast cancer, Breast Cancer Research and Treatment, 1998, 51, 3, 195

    CrossRef

  164. 164
    J Kollias, D.M Sibbering, R.W Blamey, P.A.M Holland, Z Obuszko, A.R.M Wilson, A.J Evans, I.O Ellis, C.W Elston, Screening women aged less than 50 years with a family history of breast cancer, European Journal of Cancer, 1998, 34, 6, 878

    CrossRef

  165. 165
    B. Salvadori, E. Biganzoli, P. Veronesi, R. Saccozzi, F. Rilkes, Conservative surgery for infiltrating lobular breast carcinoma, British Journal of Surgery, 1997, 84, 1, 106

    CrossRef

  166. 166
    A.J.M. Connor, S.E. Pinder, C.W. Elston, J.A. Bell, P. Wencyk, J.F.R. Robertson, R.W. Blarney, R.I. Nicholson, I.O. Ellis, Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody, The Breast, 1997, 6, 4, 171

    CrossRef

  167. 167
    D.C. Wheatley, L.J. Yeoman, H. Burrell, S.E. Pinder, A.J. Evans, A.R.M. Wilson, I.O. Ellis, C.W. Elston, J.F.R. Robertson, R.W. Blamey, Mammographic and pathological features of breast cancer detected at first incident round screening, The Breast, 1997, 6, 5, 259

    CrossRef

  168. 168
    Mary E. Northridge, George G. Rhoads, Daniel Wartenberg, Dawn Koffman, The importance of histologic type on breast cancer survival, Journal of Clinical Epidemiology, 1997, 50, 3, 283

    CrossRef

  169. 169
    L. H. Raj Wijetunga, Hugh L. Carmalt, David J. Gillett, A REVIEW OF PATHOLOGY REPORTING FOR BREAST CANCER, Australian and New Zealand Journal of Surgery, 1996, 66, 11
  170. 170
    B. Zafrani, M.-C. Vacher-Lavenu, Éléments de standardisation d'un compte rendu anatomopathologique d'un carcinome mammaire, Revue Française des Laboratoires, 1996, 1996, 286, 137

    CrossRef

  171. 171
    M.L. JENSEN, H. KIÆR, F. MELSEN, Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining, Histopathology, 1996, 29, 3
  172. 172
    Sami Shousha, New aspects in the histological diagnosis of breast carcinoma, Seminars in Surgical Oncology, 1996, 12, 1
  173. 173
    S. Chopra, A.J. Evans, S.E. Pinder, L.J. Yeoman, I.O. Ellis, C.W. Elston, A.R.M. Wilson, Pure mucinous breast cancer-mammographic and ultrasound findings, Clinical Radiology, 1996, 51, 6, 421

    CrossRef

  174. 174
    V. Kuenen-Boumeester, T.H. Van der Kwast, C.C. Claassen, M.P. Look, G.S. Liem, J.G.M. Klijn, S.C. Henzen-Logmans, The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters, European Journal of Cancer, 1996, 32, 9, 1560

    CrossRef

  175. 175
    G. MORPHOPOULOS, M. PEARSON, W. D. J. RYDER, A. HOWELL, M. HARRIS, TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN INFILTRATING LOBULAR CARCINOMA OF THE BREAST, The Journal of Pathology, 1996, 180, 1
  176. 176
    Laszlo Tabar, Gunnar Fagerberg, H. H. Chen, S. W. Duffy, A. Gad, Tumour development, histology and grade of breast cancers: Prognosis and progression, International Journal of Cancer, 1996, 66, 4
  177. 177
    E. S. Morris, C. W. Elston, J. A. Bell, M. Galea, R. W. Blamey, I. O. Ellis, An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast, The Journal of Pathology, 1995, 176, 1
  178. 178
    H Goulding, N.F Nik Abdul Rashid, J.F Robertson, J.A Bell, C.W Elston, R.W Blamey, I.O Ellis, Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?, Human Pathology, 1995, 26, 11, 1196

    CrossRef

  179. 179
    Jennet M. Harvey, Gregory F. Sterrett, Richard W. Parsons, Criena J. Fitzgerald, Konrad Jamrozik, Joanna M. Dewar, Michael J. Byrne, David M. Ingram, Harry M. Sheiner, Breast cancer in Western Australia in 1989: IV. summary of histopathological assessment in 655 cases, Pathology, 1995, 27, 1, 12

    CrossRef

  180. 180
    I. A. Robinson, G. McKee, P. A. Jackson, M. G. Cook, M. W. Kissin, Lobular carcinoma of the breast: Cytological features supporting the diagnosis of lobular cancer, Diagnostic Cytopathology, 1995, 13, 3
  181. 181
    E J Cornford, A R M Wilson, E Athanassiou, M Galea, I O Ellis, C W Elston, R W Blamey, Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis, The British Journal of Radiology, 1995, 68, 809, 450

    CrossRef

  182. 182
    H. PEREIRA, S.E. PINDER, D.M. SIBBERING, M.H. GALEA, C.W. ELSTON, R.W. BLAMEY, J.F.R. ROBERTSON, I.O. ELLIS, Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma, Histopathology, 1995, 27, 3
  183. 183
    Morten Ladekarl, Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts, Cancer, 1995, 75, 8
  184. 184
    S. E. PINDER, P. M. WENCYK, H. E. NAYLOR, J. A. BELL, C. W. ELSTON, J. F. R. ROBERTSON, R. W. BLAMEY, I. O. ELLIS, The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations, Cytopathology, 1995, 6, 5
  185. 185
    M.C. Cummings, R.G. Wright, C.M. Furnival, C.J. Bain, V. Siskind, The feasibility of retrospective grading of breast cancer histology slides derived from multiple pathology services, The Breast, 1995, 4, 3, 179

    CrossRef

  186. 186
    Gordon C. Jayson, Anthony Howell, Martin Harris, Godfrey Morgenstern, James Chang, W. David Ryder, Grad, Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant, Cancer, 1994, 74, 12
  187. 187
    W.P. Fox, W. Odling-Smee, Emotional control and histopathology in breast cancer prognosis, The Breast, 1994, 3, 3, 164

    CrossRef

  188. 188
    P.J. VAN DIEST, J.A.M. BELIËN, P.E. ZANSTRA, W.W. WILHELM, J.P.A. BAAK, Integrated decision support system/image archive for histological typing of breast cancer using a relation oriented inference system, Histopathology, 1994, 25, 3
  189. 189
    S. O'Rourke, M. H. Galea, D. Morgan, D. Euhus, S. Pinder, I. O. Ellis, C. W. Elston, R. W. Blamey, Local recurrence after simple mastectomy, British Journal of Surgery, 1994, 81, 3
  190. 190
    D. LARSIMONT, L. LESPAGNARD, M. DEGEYTER, R. HEIMANN, Medullary carcinoma of the breast: a tumour lacking keratin 19, Histopathology, 1994, 24, 6
  191. 191
    S.E. PINDER, I.O. ELLIS, M. GALEA, S. O'ROUKE, R.W. BLAMEY, C.W. ELSTON, Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up, Histopathology, 1994, 24, 1
  192. 192
    I.A. Robinson, G. McKee, A. Nicholson, P.A. Jackson, M.G. Cook, J. D'Arcy, M.W. Kissin, Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas, The Lancet, 1994, 343, 8903, 947

    CrossRef

  193. 193
    Celia Byrne, Charles R. Smart, Kenneth C. Chu, William H. Hartmann, Survival advantage differences by age: Evaluation of the extended follow-up of the breast cancer detection demonstration project, Cancer, 1994, 74, S1
  194. 194
    J.A. Stutz, A.J. Evans, S. Pinder, I.O. Ellis, L.J. Yeoman, A.R.M. Wilson, D.M. Sibbering, R.W. Blamey, C.W. Elston, J.F.R. Robertson, The radiological appearances of invasive cribriform carcinoma of the breast, Clinical Radiology, 1994, 49, 10, 693

    CrossRef

  195. 195
    I.O. Ellis, M.H. Galea, A. Locker, E.J. Roebuck, C.W. Elston, R.W. Blamey, A.R.M. Wilson, Early experience in breast cancer screening: emphasis on development of protocols for triple assessment, The Breast, 1993, 2, 3, 148

    CrossRef

  196. 196
    D.L. Page, T.J. Anderson, How should we categorize breast cancer?, The Breast, 1993, 2, 4, 217

    CrossRef

  197. 197
    Sunjay Jain, Charlotte Fisher, Paul Smith, Rosemary R. Millis, Robert D. Rubens, Patterns of metastatic breast cancer in relation to histological type, European Journal of Cancer, 1993, 29, 15, 2155

    CrossRef

  198. 198
    MORTEN LADEKARL, FLEMMING BRANDT SØRENSEN, Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast, APMIS, 1993, 101, 7-12
  199. 199
    T.J. Anderson, c-erbB-2 oncogene in breast cancer: The right target or a decoy?, Human Pathology, 1992, 23, 9, 971

    CrossRef